IL138393A0 - Methods for inhibiting mrp1 - Google Patents

Methods for inhibiting mrp1

Info

Publication number
IL138393A0
IL138393A0 IL13839399A IL13839399A IL138393A0 IL 138393 A0 IL138393 A0 IL 138393A0 IL 13839399 A IL13839399 A IL 13839399A IL 13839399 A IL13839399 A IL 13839399A IL 138393 A0 IL138393 A0 IL 138393A0
Authority
IL
Israel
Prior art keywords
methods
inhibiting mrp1
mrp1
inhibiting
Prior art date
Application number
IL13839399A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL138393A0 publication Critical patent/IL138393A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13839399A 1998-04-08 1999-04-07 Methods for inhibiting mrp1 IL138393A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8108898P 1998-04-08 1998-04-08
PCT/US1999/007615 WO1999051236A1 (en) 1998-04-08 1999-04-07 Methods for inhibiting mrp1

Publications (1)

Publication Number Publication Date
IL138393A0 true IL138393A0 (en) 2001-10-31

Family

ID=22162031

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13839399A IL138393A0 (en) 1998-04-08 1999-04-07 Methods for inhibiting mrp1

Country Status (17)

Country Link
US (1) US6221876B1 (pt)
EP (1) EP1067932A4 (pt)
JP (1) JP2002510632A (pt)
KR (1) KR20010042481A (pt)
CN (1) CN1296410A (pt)
AU (1) AU3550299A (pt)
BR (1) BR9909446A (pt)
CA (1) CA2327452A1 (pt)
EA (1) EA200001035A1 (pt)
HU (1) HUP0102548A2 (pt)
ID (1) ID26804A (pt)
IL (1) IL138393A0 (pt)
NO (1) NO20005041D0 (pt)
PL (1) PL343320A1 (pt)
SK (1) SK14992000A3 (pt)
TR (1) TR200002804T2 (pt)
WO (1) WO1999051236A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262098B1 (en) * 1998-08-07 2001-07-17 Chiron Corporation Estrogen receptor modulators
US6743794B2 (en) 1999-12-22 2004-06-01 Eli Lilly And Company Methods and compounds for inhibiting MRP1
ATE282623T1 (de) * 1999-12-22 2004-12-15 Lilly Co Eli Verfahren und verbindungen für die hemmung von mrp1
EP1301518A1 (en) 2000-06-14 2003-04-16 Eli Lilly And Company Tricyclic compounds as mrp1-inhibitors
CA2442605A1 (en) 2001-04-09 2002-10-17 Mark Christopher Lohman Compounds and methods for inhibiting mrp1
CN1281210C (zh) * 2003-11-29 2006-10-25 胡汛 五味子乙素在制备治疗肿瘤药物中的应用
ATE396725T1 (de) * 2004-05-14 2008-06-15 Cleveland Clinic Foundation Kleinmolekülige hemmer für mrp1 und andere multiarzneimitteltransporter

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182290A (en) * 1991-08-27 1993-01-26 Neurogen Corporation Certain oxazoloquinolinones; a new class of GABA brain receptor ligands

Also Published As

Publication number Publication date
CA2327452A1 (en) 1999-10-14
US6221876B1 (en) 2001-04-24
NO20005041L (no) 2000-10-06
CN1296410A (zh) 2001-05-23
EP1067932A1 (en) 2001-01-17
KR20010042481A (ko) 2001-05-25
EA200001035A1 (ru) 2001-04-23
NO20005041D0 (no) 2000-10-06
TR200002804T2 (tr) 2001-02-21
PL343320A1 (en) 2001-08-13
EP1067932A4 (en) 2001-11-14
HUP0102548A2 (hu) 2001-11-28
AU3550299A (en) 1999-10-25
SK14992000A3 (sk) 2001-06-11
WO1999051236A1 (en) 1999-10-14
JP2002510632A (ja) 2002-04-09
BR9909446A (pt) 2000-12-12
ID26804A (id) 2001-02-08

Similar Documents

Publication Publication Date Title
IL139955A0 (en) Lantithrombotic compounds
GB9919873D0 (en) Compounds
IL138389A0 (en) Methods for inhibiting mrp1
IL138391A0 (en) Methods for inhibiting mrp1
IL138393A0 (en) Methods for inhibiting mrp1
GB9803322D0 (en) Methods
GB9814199D0 (en) Novel method
HU9800230V0 (en) Bandbaluster for boondary
PL327557A1 (en) Micro-agitator for emulssions
GB9806323D0 (en) Services-connections for trailer-vehicles
TW345033U (en) Improvement for filtering-core
TW345035U (en) Improvement for filtering-core
HU9800093V0 (en) Skate-board for field
GB9813912D0 (en) Methods
GB9827407D0 (en) Methods
GB9824856D0 (en) Methods
GB9824501D0 (en) Methods
GB9828697D0 (en) Inhibitors
GB9826992D0 (en) Inhibitors
GB9803416D0 (en) Inhibitors
GB9815872D0 (en) Novel method
GB9812227D0 (en) Novel method
GB9814157D0 (en) Novel method
GB9806706D0 (en) Novel method
GB9810576D0 (en) Novel method